Nothing found. Try the Latin name or the product name.
Search
Nothing found. Try the Latin name or the product name.
Baytril
Enrofloxacin · Elanco GmbH, Elanco US Inc.
9 forms: scored tablet, solution, tablet. No registration in force in Georgia.
Forms and doses0 of 9 in force in Georgia
The dose from the product's label, by species and weight. Check the label of the pack you use.
| Form | Species | Dose | Frequency | Georgia | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 mg, Tablet · Cat | Cat | Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg | once daily or split into two doses, for 3-10 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
| 15 mg, Tablet · Dog | Dog | Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg | once daily or split into two doses, for 3-10 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
Details: pack, label wording, sources, registrationFlavour tablet, enrofloxacin 15 mg, for cats and dogs Composition / strength
Enrofloxacin15 mg
Formulation Type Tablet Administration route By mouth Manufacturer Registration
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Source:
VMD SPC 2025
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2025
Source:
VMD SPC 2025
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2025 | ||||||||||||
| 22.7 mg, Scored tablet · Cat | Cat | Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg | once daily or two equal doses 12 hours apart, up to 30 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
| 22.7 mg, Scored tablet · Dog | Dog | Susceptible bacterial infections in dogs and cats · By mouth: 5–20 mg/kg | once daily or two equal doses 12 hours apart, up to 30 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
Details: pack, label wording, sources, registrationBaytril 22.7 mg, Scored tabletTaste Tabs scored tablet, enrofloxacin 22.7 mg, for dogs and cats Composition / strength
Enrofloxacin22.7 mg
Formulation Type Scored tablet Administration route By mouth Manufacturer Registration
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Source:
FDA 2026
Official product label (SPC), FDA, US Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there. US Food and Drug Administration, via DailyMed, 2026
Source:
FDA 2026
Official product label (SPC), FDA, US Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there. US Food and Drug Administration, via DailyMed, 2026 | ||||||||||||
| 22.7 mg/ml, Solution · Cat | Cat | Susceptible bacterial infections in dogs and cats · Intramuscular: No dose for this species | - |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
| 22.7 mg/ml, Solution · Dog | Dog | Susceptible bacterial infections in dogs and cats · Intramuscular: 2.5 mg/kg | single initial IM dose; tablets 12 hours later |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
Details: pack, label wording, sources, registrationBaytril 22.7 mg/ml, Solutionenrofloxacin, solution for injection for dogs Composition / strength
Enrofloxacin22.7 mg/ml
Formulation Type Solution Administration route Intramuscular Manufacturer Registration
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Source:
FDA label
Official product label (SPC), FDA, US Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there. DailyMed, U.S. National Library of Medicine, 2026
Source:
FDA label
Official product label (SPC), FDA, US Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there. DailyMed, U.S. National Library of Medicine, 2026 | ||||||||||||
| 25 mg/ml (2.5%), Solution · Cat | Cat | Susceptible bacterial infections in dogs and cats · Subcutaneous: 5 mg/kg | once daily SC, for up to 5 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
| 25 mg/ml (2.5%), Solution · Dog | Dog | Susceptible bacterial infections in dogs and cats · Subcutaneous: 5 mg/kg | once daily SC, for up to 5 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
Details: pack, label wording, sources, registrationBaytril 25 mg/ml (2.5%), Solutionenrofloxacin, solution for injection for dogs and cats Composition / strength
Enrofloxacin25 mg/ml
Formulation Type Solution Administration route Subcutaneous, Intramuscular Manufacturer Registration
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Source:
VMD SPC 2026
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2026
Source:
VMD SPC 2026
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2026 | ||||||||||||
| 50 mg, Tablet · Cat | Cat | Susceptible bacterial infections in dogs and cats · By mouth: No dose for this species | - |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
| 50 mg, Tablet · Dog | Dog | Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg | once daily or split into two doses, for 3-10 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
Details: pack, label wording, sources, registrationBaytril 50 mg, TabletFlavour tablet, enrofloxacin 50 mg, for dogs Composition / strength
Enrofloxacin50 mg
Formulation Type Tablet Administration route By mouth Manufacturer Registration
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Source:
VMD SPC
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2025
Source:
VMD SPC
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2025 | ||||||||||||
| 50 mg/ml (5%), Solution · Cat | Cat | Susceptible bacterial infections in dogs and cats · Subcutaneous: 5 mg/kg | once daily SC, for up to 5 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
| 50 mg/ml (5%), Solution · Dog | Dog | Susceptible bacterial infections in dogs and cats · Subcutaneous: 5 mg/kg | once daily SC, for up to 5 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
Details: pack, label wording, sources, registrationBaytril 50 mg/ml (5%), Solutionenrofloxacin, solution for injection for dogs and cats Composition / strength
Enrofloxacin50 mg/ml
Formulation Type Solution Administration route Subcutaneous, Intramuscular, Intravenous Manufacturer Registration
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Source:
VMD SPC
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2026
Source:
VMD SPC
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2026 | ||||||||||||
| 68 mg, Scored tablet · Cat | Cat | Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg | once daily or two equal doses 12 hours apart, up to 30 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
| 68 mg, Scored tablet · Dog | Dog | Susceptible bacterial infections in dogs and cats · By mouth: 5–20 mg/kg | once daily or two equal doses 12 hours apart, up to 30 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
Details: pack, label wording, sources, registrationBaytril 68 mg, Scored tabletTaste Tabs scored tablet, enrofloxacin 68 mg, for dogs and cats Composition / strength
Enrofloxacin68 mg
Formulation Type Scored tablet Administration route By mouth Manufacturer Registration
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Source:
FDA 2026
Official product label (SPC), FDA, US Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there. US Food and Drug Administration, via DailyMed, 2026
Source:
FDA 2026
Official product label (SPC), FDA, US Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there. US Food and Drug Administration, via DailyMed, 2026 | ||||||||||||
| 136 mg, Scored tablet · Cat | Cat | Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg | once daily or two equal doses 12 hours apart, up to 30 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
| 136 mg, Scored tablet · Dog | Dog | Susceptible bacterial infections in dogs and cats · By mouth: 5–20 mg/kg | once daily or two equal doses 12 hours apart, up to 30 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
Details: pack, label wording, sources, registrationBaytril 136 mg, Scored tabletTaste Tabs scored tablet, enrofloxacin 136 mg, for dogs and cats Composition / strength
Enrofloxacin136 mg
Formulation Type Scored tablet Administration route By mouth Manufacturer Registration
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Source:
FDA 2026
Official product label (SPC), FDA, US Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there. US Food and Drug Administration, via DailyMed, 2026
Source:
FDA 2026
Official product label (SPC), FDA, US Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there. US Food and Drug Administration, via DailyMed, 2026 | ||||||||||||
| 150 mg, Tablet · Cat | Cat | Susceptible bacterial infections in dogs and cats · By mouth: No dose for this species | - |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
| 150 mg, Tablet · Dog | Dog | Susceptible bacterial infections in dogs and cats · By mouth: 5 mg/kg | once daily or split into two doses, for 3-10 days |
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 |
||||||||
Details: pack, label wording, sources, registrationBaytril 150 mg, TabletFlavour tablet, enrofloxacin 150 mg, for dogs Composition / strength
Enrofloxacin150 mg
Formulation Type Tablet Administration route By mouth Manufacturer Registration
Georgia
No
Not registered in Georgia
Veterinary (National Food Agency)
Verified on: 29 Oct 2026 Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Source:
VMD SPC
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2025
Source:
VMD SPC
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2025 | ||||||||||||
Active substance doses, with sources
| Dose | Species | Indication | Route | Frequency | Source |
|---|---|---|---|---|---|
| 5 mg/kg | Dog, Cat | Bacterial Infection; Urinary Tract Infection; Skin and Soft Tissue Infection | By mouth / Subcutaneous | once daily |
VMD SPC 2025
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2025 VMD SPC 2025
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2025 VMD SPC 2026
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2026 VMD SPC 2026
Official product label (SPC), VMD, UK Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there. UK Veterinary Medicines Directorate, Product Information Database, 2026 FDA 2026
Official product label (SPC), FDA, US Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there. US Food and Drug Administration, via DailyMed, 2026 |
| 5–20 mg/kg | Dog | Bacterial Infection | By mouth | once daily |
FDA 2026
Official product label (SPC), FDA, US Approved by the US Food and Drug Administration (FDA) as part of the product's authorisation. It applies to that product as authorised there. US Food and Drug Administration, via DailyMed, 2026 |
| 10–20 mg/kg | Dog | Skin and Soft Tissue Infection | By mouth | once daily |
ISCAID 2025
Guideline or consensus statement Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product. Veterinary Dermatology, 2025 |
Known Contraindications
-
Critical
Do not use enrofloxacin in animals with epilepsy, seizures, or seizure disorders associated with the central nervous system, because it may stimulate the CNS.Sources: VMD SPC · VMD · FDA
-
Critical
Do not use in animals hypersensitive to the active substance, another fluoroquinolone, or any excipient. Do not use against known quinolone resistance because cross-resistance is extensive. Treat Pseudomonas infections only after susceptibility testing.Sources: VMD SPC · VMD
-
Warning
Elimination may be delayed in animals with pre-existing renal damage. Use with caution in severe renal or hepatic impairment.Sources: VMD SPC · VMD
-
Warning
Use with caution in severe hepatic impairment. Concomitant administration with other hepatically metabolized medicines may reduce clearance of both the quinolone and the other medicine.Sources: VMD SPC · VMD · FDA
-
Warning
The use is not recommended during pregnancy The safety of the veterinary medicinal product has not been established during pregnancy and lactation Safety in breeding or pregnant cats has not been established The veterinary medicinal product may be used safely in pregnant and lactating animalsSources: VMD · FDA
-
Warning
the use is not recommended during lactation may be used safely in pregnant and lactating animalsSources: VMD
-
Warning
(Dog) Not for use in dogs less than 1 year of age, or in exceptionally large breeds with a longer growth period under 18 months of age (Baytril tablets, VMD). The limit differs by product: Baytril injection, small breeds under 8 months, large under 12 months, giant under 18 months; Xeden, under 12 months (small breeds) or 18 months (large breeds); FDA, contraindicated in small and medium breeds aged 2 to 8 months. Use the limit of your product; the reason is cartilage damage during growth.Sources: VMD · FDA
-
Warning
(Cat) Overdose risk: in rare instances, use of enrofloxacin in cats has been associated with retinal toxicity. Do not exceed 5 mg/kg of body weight per day in cats (FDA). From 20 mg/kg: mydriasis, retinal degeneration and loss of vision. Mydriasis may be an indication of impending or existing retinal changes: if the pupils dilate during treatment, stop and examine the eyes.Sources: FDA
-
Warning
(Cat) Minimum age differs by product. Some labels prohibit use in kittens younger than 8 weeks; others prohibit use below 3 months of age or below 1 kg because of cartilage injury risk. Use the limit stated for the specific product; the most conservative limit is 3 months and 1 kg.Sources: FDA
Known Drug Interactions
-
Major warning
Enrofloxacin + Aminophylline
Theophylline metabolism is inhibited by erythromycin, cimetidine, propranolol, enrofloxacin, and marbofloxacinRecommendation: Reduce the aminophylline dose during concomitant use. Signs of toxicity include vomiting, excitation, tachyarrhythmia, and seizures.Sources: MSD Vet Manual
-
Major warning
Enrofloxacin + Doxycycline
Do not combine enrofloxacin with antimicrobials that act antagonistically to quinolones, including macrolides, tetracyclines such as doxycycline, and phenicols such as chloramphenicol.Recommendation: Do not administer concurrently. Based on susceptibility testing, choose either a bactericidal fluoroquinolone or a bacteriostatic tetracycline.Sources: VMD SPC · VMD
-
Major warning
Enrofloxacin + Theophylline
Do not use concurrently with theophylline as the elimination of theophylline may be delayed Concomitant administration of theophylline requires careful monitoring as serum levels of theophylline may increaseRecommendation: Avoid the combination where possible. If concomitant use is unavoidable, monitor serum theophylline and be prepared to reduce its dose.Sources: VMD
-
Minor warning
Enrofloxacin + Sucralfate
The concomitant administration of substances containing magnesium or aluminium may reduce the absorption of enrofloxacin. These drugs should be administered two hours apart.Recommendation: Separation is not critical in dogs, but a 2-hour interval is safe and label-consistent. No comparable measurement exists in cats; use a 2-hour interval in cats.Sources: VMD SPC · VMD · JVIM
Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.
For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.
Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.
The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.
This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 29 Oct 2026